Platelets and infections - Complex interactions with bacteria

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Hamzeh Cognasse, Hind ^a   Damien, Pauline ^a   Chabert, Adrien ^a   Pozzetto, Bruno ^a   Cognasse, Fabrice ^a,b   Garraud, Olivier ^a,c  

^a UNIVERSITÉ DE LYON   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Adhesion; Chemokine; Cytokine; Infection; Inflammation; Platelet; Sepsis

Indexed keywords

BACTERIAL TOXIN; COMPLEMENT RECEPTOR; FC RECEPTOR; FC RECEPTOR IIA; FIBRINOGEN; FIBRONECTIN; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; INTEGRIN; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR; VON WILLEBRAND FACTOR;

APOPTOSIS; BACTERIA; BACTERIAL ENDOCARDITIS; BACTERIUM ADHERENCE; BLOOD CLOTTING DISORDER; CHLAMYDOPHILA PNEUMONIAE; HEMOSTASIS; IMMUNE SYSTEM; IMMUNOMODULATION; INFECTION; INTERNALIZATION; MICROENVIRONMENT; NONHUMAN; PHAGOLYSOSOME; PLATELET MICROPARTICLE; PORPHYROMONAS GINGIVALIS; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS SANGUINIS; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOSIS;

EID: 84926622731     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00082     Document Type: Review

References (182)

1. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity (2003) 19:9-19. doi: 10.1016/S1074-7613(03)00177-8
2. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol (2004) 25:489-95. doi:10.1016/j.it.2004.07.003
3. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol (2011) 11:264-74. doi:10.1038/nri2956
4. Garraud O, Hamzeh-Cognasse H, Pozzetto B, Cavaillon JM, Cognasse F. Bench-to-bedside review: platelets and active immune functions-new clues for immunopathology? Crit Care (2013) 17:236. doi:10.1186/cc12716
5. Beynon RP, Bahl VK, Prendergast BD. Infective endocarditis. BMJ (2006) 333:334-9. doi:10.1136/bmj.333.7563.334
6. Leask RL, Jain N, Butany J. Endothelium and valvular diseases of the heart. Microsc Res Tech (2003) 60:129-37. doi:10.1002/jemt.10251
7. Pessi T, Karhunen V, Karjalainen PP, Ylitalo A, Airaksinen JK, Niemi M, et al. Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation (2013) 127(1219-1228):e1211-6. doi:10.1161/CIRCULATIONAHA.112.001254
8. McAdow M, Missiakas DM, Schneewind O. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J Innate Immun (2012) 4:141-8. doi:10.1159/000333447
9. Moreillon P, Entenza JM, Francioli P, Mcdevitt D, Foster TJ, Francois P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun (1995) 63:4738-43.
10. Levi M, Schultz M, Van Der Poll T. Sepsis and thrombosis. Semin Thromb Hemost (2013) 39:559-66. doi:10.1055/s-0033-1343894
11. Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost (2006) 32:11-23. doi:10.1055/s-2006-933336
12. Clawson CC, Rao GH, White JG. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol (1975) 81:411-20.
13. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost (2009) 101:439-51. doi:10.1160/TH08-08-0521
14. Nomura S, Fukuhara S. Platelet microparticles. Methods Mol Biol (2004) 272:269-77. doi:10.1385/1-59259-782-3:269
15. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis (2006) 36:182-7. doi:10.1016/j.bcmd.2005.12.019
16. Wiedmer T, Sims PJ. Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood (1991) 78:2880-6.
17. Hashimoto K, Jayachandran M, Owen WG, Miller VM. Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women. J Cardiovasc Pharmacol (2009) 54:57-62. doi:10.1097/FJC.0b013e3181ab373d
18. Brown GT, McIntyre TM. Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1beta-rich microparticles. J Immunol (2011) 186:5489-96. doi:10.4049/jimmunol.1001623
19. Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmas P, Clemetson KJ, Nagy B Jr. Distinct effects of Re-and S-forms of LPS on modulating platelet activation. J Thromb Haemost (2013) 11(4):775-8. doi:10.1111/jth.12151
20. Ge S, Hertel B, Emden SH, Beneke J, Menne J, Haller H, et al. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. Nephrol Dial Transplant (2012) 27:2768-75. doi:10.1093/ndt/gfr748
21. Italiano JE Jr, Mairuhu AT, Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 17:578-84. doi:10.1097/MOH.0b013e32833e77ee
22. George FD. Microparticles in vascular diseases. Thromb Res (2008) 122(Suppl 1):S55-9. doi:10.1016/S0049-3848(08)70020-3
23. Vasina E, Heemskerk JW, Weber C, Koenen RR. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets (2010) 9:346-54. doi:10.2174/187152810793938008
24. Markiewicz M, Richard E, Marks N, Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res (2013) 2013:734509. doi:10.1155/2013/734509
25. Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood (2007) 110:2432-9. doi:10.1182/blood-2007-02-069997
26. Mause SF, Von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol (2005) 25:1512-8. doi:10.1161/01.ATV.0000170133.43608.37
27. Sowa JM, Crist SA, Ratliff TL, Elzey BD. Platelet influence on T-and B-cell responses. Arch Immunol Ther Exp (2009) 57:235-41. doi:10.1007/s00005-009-0032-y
28. Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis (1995) 21:217-31. doi:10.1006/bcmd.1995.0025
29. Lo SC, Hung CY, Lin DT, Peng HC, Huang TF. Involvement of platelet glycoprotein Ib in platelet microparticle mediated neutrophil activation. J Biomed Sci (2006) 13:787-96. doi:10.1007/s11373-006-9107-5
30. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science (2010) 327:580-3. doi:10.1126/science.1181928
31. Ogura H, Kawasaki T, Tanaka H, Koh T, Tanaka R, Ozeki Y, et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma (2001) 50:801-9. doi:10.1097/00005373-200105000-00005
32. Wang J, Zhang W, Nardi MA, Li Z. HIV-1 Tat induced-platelet activation and release of CD154 contribute to HIV-1 associated autoimmune thrombocytopenia. J Thromb Haemost (2011) 9(3):562-73. doi:10.1111/j.1538-7836.2010.04168.x
33. Calvete JJ. Platelet integrin GPIIb/IIIa: structure-function correlations. An update and lessons from other integrins. Proc Soc Exp Biol Med (1999) 222:29-38. doi:10.1111/j.1525-1373.1999.09993.pp.x
34. Bennett JS, Berger BW, Billings PC. The structure and function of platelet integrins. J Thromb Haemost (2009) 7(Suppl 1):200-5. doi:10.1111/j.1538-7836.2009.03378.x
35. Josefsson E, Mccrea KW, Ni Eidhin D, O'connell D, Cox J, Hook M, et al. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology (1998) 144(Pt 12):3387-95. doi:10.1099/00221287-144-12-3387
36. McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol (1994) 11:237-48. doi:10.1111/j.1365-2958.1994.tb00304.x
37. Ni Eidhin D, Perkins S, Francois P, Vaudaux P, Hook M, Foster TJ. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol (1998) 30:245-57. doi:10.1046/j.1365-2958.1998.01050.x
38. Flock JI, Froman G, Jonsson K, Guss B, Signas C, Nilsson B, et al. Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J (1987) 6:2351-7.
39. Mitchell J, Tristan A, Foster TJ. Characterization of the fibrinogen-binding surface protein Fbl of Staphylococcus lugdunensis. Microbiology (2004) 150:3831-41. doi:10.1099/mic.0.27337-0
40. Usui Y, Ohshima Y, Ichiman Y, Ohtomo T, Suganuma M, Yoshida K. Platelet aggregation induced by strains of various species of coagulase-negative staphylococci. Microbiol Immunol (1991) 35:15-26. doi:10.1111/j.1348-0421.1991.tb01529.x
41. Brennan MP, Loughman A, Devocelle M, Arasu S, Chubb AJ, Foster TJ, et al. Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G in platelet activation. J Thromb Haemost (2009) 7:1364-72. doi:10.1111/j.1538-7836.2009.03495.x
42. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost (2011) 9:1097-107. doi:10.1111/j.1538-7836.2011.04264.x
43. Miajlovic H, Zapotoczna M, Geoghegan JA, Kerrigan SW, Speziale P, Foster TJ. Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets. Microbiology (2010) 156:920-8. doi:10.1099/mic.0.036673-0
44. Petersen HJ, Keane C, Jenkinson HF, Vickerman MM, Jesionowski A, Waterhouse JC, et al. Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infect Immun (2010) 78:413-22. doi:10.1128/IAI.00664-09
45. Plummer C, Wu H, Kerrigan SW, Meade G, Cox D, Ian Douglas CW. A serine-rich glycoprotein of Streptococcus sanguinis mediates adhesion to platelets via GPIb. Br J Haematol (2005) 129:101-9. doi:10.1111/j.1365-2141.2005.05421.x
46. Bensing BA, Lopez JA, Sullam PM. The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Ibalpha. Infect Immun (2004) 72:6528-37. doi:10.1128/IAI.72.11.6528-6537.2004
47. Siboo IR, Chambers HF, Sullam PM. Role of SraP, a serine-rich surface protein of Staphylococcus aureus, in binding to human platelets. Infect Immun (2005) 73:2273-80. doi:10.1128/IAI.73.4.2273-2280.2005
48. O'Seaghdha M, Van Schooten CJ, Kerrigan SW, Emsley J, Silverman GJ, Cox D, et al. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS J (2006) 273:4831-41. doi:10.1111/j.1742-4658.2006.05482.x
49. Thomer L, Schneewind O, Missiakas D. Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. J Biol Chem (2013) 288:28283-92. doi:10.1074/jbc.M113.493122
50. Claes J, Vanassche T, Peetermans M, Liesenborghs L, Vandenbriele C, Vanhoorelbeke K, et al. Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor-binding protein. Blood (2014) 124:1669-76. doi:10.1182/blood-2014-02-558890
51. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology (2003) 124:1846-54. doi:10.1016/S0016-5085(03)00397-4
52. Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol (2010) 47:2170-5. doi:10.1016/j.molimm.2010.05.009
53. Verschoor A, Langer HF. Crosstalk between platelets and the complement system in immune protection and disease. Thromb Haemost (2013) 110:910-9. doi:10.1160/TH13-02-0102
54. Gadjeva M. The complement system. Overview. Methods Mol Biol (2014) 1100:1-9. doi:10.1007/978-1-62703-724-2_1
55. Ford I, Douglas CW, Heath J, Rees C, Preston FE. Evidence for the involvement of complement proteins in platelet aggregation by Streptococcus sanguinis NCTC 7863. Br J Haematol (1996) 94:729-39. doi:10.1046/j.1365-2141.1996.d01-1857.x
56. Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, Cox D, et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol (2005) 57:804-18. doi:10.1111/j.1365-2958.2005.04731.x
57. Peerschke EI, Murphy TK, Ghebrehiwet B. Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost (2003) 89:331-9. doi:10.1267/THRO03020331
58. Hamad OA, Nilsson PH, Wouters D, Lambris JD, Ekdahl KN, Nilsson B. Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1. J Immunol (2010) 184:2686-92. doi:10.4049/jimmunol.0902810
59. Schmaier AH, Smith PM, Colman RW. Platelet C1-inhibitor. A secreted alpha-granule protein. J Clin Invest (1985) 75:242-50. doi:10.1172/JCI111680
60. Capel PJ, Van De Winkel JG, Van Den Herik-Oudijk IE, Verbeek JS. Heterogeneity of human IgG Fc receptors. Immunomethods (1994) 4:25-34. doi:10.1006/immu.1994.1004
61. Cassel DL, Keller MA, Surrey S, Schwartz E, Schreiber AD, Rappaport EF, et al. Differential expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC in hematopoietic cells: analysis of transcripts. Mol Immunol (1993) 30:451-60. doi:10.1016/0161-5890(93)90113-P
62. Reilly RF. The pathophysiology of immune-mediated heparin-induced thrombocytopenia. Semin Dial (2003) 16:54-60. doi:10.1046/j.1525-139X.2003.03013.x
63. Worth RG, Chien CD, Chien P, Reilly MP, Mckenzie SE, Schreiber AD. Platelet FcgammaRIIA binds and internalizes IgG-containing complexes. Exp Hematol (2006) 34:1490-5. doi:10.1016/j.exphem.2006.06.015
64. Fitzpatrick RE, Wijeyewickrema LC, Pike RN. The gingipains: scissors and glue of the periodontal pathogen, Porphyromonas gingivalis. Future Microbiol (2009) 4:471-87. doi:10.2217/fmb.09.18
65. Arvand M, Bhakdi S, Dahlback B, Preissner KT. Staphylococcus aureus alpha-toxin attack on human platelets promotes assembly of the prothrombinase complex. J Biol Chem (1990) 265:14377-81.
66. Bryant AE, Bayer CR, Chen RY, Guth PH, Wallace RJ, Stevens DL. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J Infect Dis (2005) 192:1014-22. doi:10.1086/432729
67. Johnson MK, Boese-Marrazzo D, Pierce WA Jr. Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect Immun (1981) 34:171-6.
68. Clawson CC. Platelet interaction with bacteria. 3. Ultrastructure. Am J Pathol (1973) 70:449-71.
69. Clawson CC, White JG. Platelet interaction with bacteria. V. Ultrastructure of congenital afibrinogenemic platelets. Am J Pathol (1980) 98:197-211.
70. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood (2002) 99:4021-9. doi:10.1182/blood-2001-12-0191
71. Li X, Iwai T, Nakamura H, Inoue Y, Chen Y, Umeda M, et al. An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation. Thromb Res (2008) 122:810-9. doi:10.1016/j.thromres.2008.03.011
72. Antczak AJ, Vieth JA, Singh N, Worth RG. Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets. Clin Vaccine Immunol (2011) 18:210-6. doi:10.1128/CVI.00296-10
73. White JG. Why human platelets fail to kill bacteria. Platelets (2006) 17:191-200. doi:10.1080/09537100500441234
74. Abdulrehman AY, Jackson EC, Mcnicol A. Platelet activation by Streptococcus sanguinis is accompanied by MAP kinase phosphorylation. Platelets (2013) 24:6-14. doi:10.3109/09537104.2012.661105
75. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penades J, Litt D, et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol (2002) 44:1033-44. doi:10.1046/j.1365-2958.2002.02935.x
76. Sullam PM, Hyun WC, Szollosi J, Dong J, Foss WM, Lopez JA. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcgammaRIIA on the platelet plasma membrane. J Biol Chem (1998) 273:5331-6. doi:10.1074/jbc.273.9.5331
77. Sun B, Li J, Kambayashi J. Interaction between GPIbalpha and FcgammaIIA receptor in human platelets. Biochem Biophys Res Commun (1999) 266:24-7. doi:10.1006/bbrc.1999.1761
78. Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ. Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood (2008) 112:2780-6. doi:10.1182/blood-2008-02-142125
79. Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci (2010) 67:513-23. doi:10.1007/s00018-009-0207-z
80. Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, et al. Deciphering the human platelet sheddome. Blood (2011) 117:e15-26. doi:10.1182/blood-2010-05-283838
81. Karshovska E, Weber C, Von Hundelshausen P. Platelet chemokines in health and disease. Thromb Haemost (2013) 110:894-902. doi:10.1160/TH13-04-0341
82. McNicol A, Agpalza A, Jackson EC, Hamzeh-Cognasse H, Garraud O, Cognasse F. Streptococcus sanguinis-induced cytokine release from platelets. J Thromb Haemost (2011) 9:2038-49. doi:10.1111/j.1538-7836.2011.04462.x
83. Haaland HD, Holmsen H. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro. Platelets (2011) 22:328-37. doi:10.3109/09537104.2011.551949
84. Krauel K, Weber C, Brandt S, Zahringer U, Mamat U, Greinacher A, et al. Platelet factor 4 binding to lipid A of gram-negative bacteria exposes PF4/heparin-like epitopes. Blood (2012) 120:3345-52. doi:10.1182/blood-2012-06-434985
85. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation (2002) 106:896-9. doi:10.1161/01.CIR.0000028962.04520.01
86. Garraud O, Hamzeh-Cognasse H, Cognasse F. Platelets and cytokines: how and why? Transfus Clin Biol (2012) 19:104-8. doi:10.1016/j.tracli.2012.02.004
87. Cognasse F, Lafarge S, Chavarin P, Acquart S, Garraud O. Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9. Intensive Care Med (2007) 33:382-4. doi:10.1007/s00134-006-0488-8
88. Knapp S, Von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, et al. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol (2008) 180:3478-84. doi:10.4049/jimmunol.180.5.3478
89. Assinger A, Laky M, Schabbauer G, Hirschl AM, Buchberger E, Binder BR, et al. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J Thromb Haemost (2011) 9:799-809. doi:10.1111/j.1538-7836.2011.04193.x
90. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood (2011) 118:1952-61. doi:10.1182/blood-2011-03-343061
91. Assinger A, Laky M, Badrnya S, Esfandeyari A, Volf I. Periodontopathogens induce expression of CD40L on human platelets via TLR2 and TLR4. Thromb Res (2012) 130:e73-8. doi:10.1016/j.thromres.2012.04.017
92. Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost (2005) 94:831-8. doi:10.1160/TH05-01-0009
93. Stahl AL, Svensson M, Morgelin M, Svanborg C, Tarr PI, Mooney JC, et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets via TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood (2006) 108:167-76. doi:10.1182/blood-2005-08-3219
94. Clark SR, Ma AC, Tavener SA, Mcdonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med (2007) 13:463-9. doi:10.1038/nm1565
95. Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol (2007) 102:429-33. doi:10.1152/japplphysiol.01576.2005
96. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol (2009) 182:7997-8004. doi:10.4049/jimmunol.0802884
97. Soliman A, Michelsen KS, Karahashi H, Lu J, Meng FJ, Qu X, et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. PLoS One (2010) 5:e15044. doi:10.1371/journal.pone.0015044
98. Wang B, Wang YQ, Cao SH, Liang Y. [Platelet parameters and platelet toll-like receptor 4 (TLR4) expression in patients with sepsis, and the effect of a joint treatment-plan integrating traditional Chinese and western medicine: a clinical study]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2011) 23:616-20.
99. Berthet J, Damien P, Hamzeh-Cognasse H, Arthaud CA, Eyraud MA, Zeni F, et al. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol (2012) 145:189-200. doi:10.1016/j.clim.2012.09.004
100. Kraemer BF, Campbell RA, Schwertz H, Cody MJ, Franks Z, Tolley ND, et al. Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog (2011) 7:e1002355. doi:10.1371/journal.ppat.1002355
101. Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol (2013) 13:47. doi:10.1186/1471-2180-13-47
102. Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci (2010) 67:525-44. doi:10.1007/s00018-009-0210-4
103. Trier DA, Gank KD, Kupferwasser D, Yount NY, French WJ, Michelson AD, et al. Platelet antistaphylococcal responses occur through P2X1 and P2Y12 receptor-induced activation and kinocidin release. Infect Immun (2008) 76:5706-13. doi:10.1128/IAI.00935-08
104. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol (2003) 74:448-55. doi:10.1189/jlb.0103024
105. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun (2002) 70:6524-33. doi:10.1128/IAI.70.12.6524-6533.2002
106. Yeaman MR, Yount NY, Waring AJ, Gank KD, Kupferwasser D, Wiese R, et al. Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins. Biochim Biophys Acta (2007) 1768:609-19. doi:10.1016/j.bbamem.2006.11.010
107. Agerberth B, Gudmundsson GH. Host antimicrobial defence peptides in human disease. Curr Top Microbiol Immunol (2006) 306:67-90. doi:10.1007/3-540-29916-5_3
108. Guani-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Teran LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol (2010) 135:1-11. doi:10.1016/j.clim.2009.12.004
109. Tohidnezhad M, Varoga D, Podschun R, Wruck CJ, Seekamp A, Brandenburg LO, et al. Thrombocytes are effectors of the innate immune system releasing human beta defensin-3. Injury (2011) 42:682-6. doi:10.1016/j.injury.2010.12.010
110. Tohidnezhad M, Varoga D, Wruck CJ, Podschun R, Sachweh BH, Bornemann J, et al. Platelets display potent antimicrobial activity and release human beta-defensin 2. Platelets (2012) 23:217-23. doi:10.3109/09537104.2011.610908
111. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA (2005) 293:3012-21. doi:10.1001/jama.293.24.3012
112. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 298:1763-71. doi:10.1001/jama.298.15.1763
113. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol (2006) 4:445-57. doi:10.1038/nrmicro1425
114. Sullam PM, Bayer AS, Foss WM, Cheung AL. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun (1996) 64:4915-21.
115. Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect Immun (1995) 63:3634-41.
116. Fitzgerald JR, Loughman A, Keane F, Brennan M, Knobel M, Higgins J, et al. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol Microbiol (2006) 59:212-30. doi:10.1111/j.1365-2958.2005.04922.x
117. Zapotoczna M, Jevnikar Z, Miajlovic H, Kos J, Foster TJ. Iron-regulated surface determinant B (IsdB) promotes Staphylococcus aureus adherence to and internalization by non-phagocytic human cells. Cell Microbiol (2013) 15:1026-41. doi:10.1111/cmi.12097
118. Heptinstall S. Platelet activation by an extracellular adherence protein from Staphylococcus aureus acting via modulation of sulfhydryl groups on platelets. Arterioscler Thromb Vasc Biol (2012) 32:1751-2. doi:10.1161/ATVBAHA.112.252460
119. Schubert S, Schwertz H, Weyrich AS, Franks ZG, Lindemann S, Otto M, et al. Staphylococcus aureus alpha-toxin triggers the synthesis of B-cell lymphoma 3 by human platelets. Toxins (Basel) (2011) 3:120-33. doi:10.3390/toxins3020120
120. Parimon T, Li Z, Bolz DD, Mcindoo ER, Bayer CR, Stevens DL, et al. Staphylococcus aureus alpha-hemolysin promotes platelet-neutrophil aggregate formation. J Infect Dis (2013) 208:761-70. doi:10.1093/infdis/jit235
121. Vanassche T, Kauskot A, Verhaegen J, Peetermans WE, Van Ryn J, Schneewind O, et al. Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation. Thromb Haemost (2012) 107:1107-21. doi:10.1160/TH11-12-0891
122. Tran U, Boyle T, Shupp JW, Hammamieh R, Jett M. Staphylococcal enterotoxin B initiates protein kinase C translocation and eicosanoid metabolism while inhibiting thrombin-induced aggregation in human platelets. Mol Cell Biochem (2006) 288:171-8. doi:10.1007/s11010-006-9134-6
123. Waller AK, Sage T, Kumar C, Carr T, Gibbins JM, Clarke SR. Staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor. J Infect Dis (2013) 208:2046-57. doi:10.1093/infdis/jit398
124. Shannon O, Uekotter A, Flock JI. Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus as an antiplatelet agent in vivo. Thromb Haemost (2005) 93:927-31. doi:10.1267/THRO05050927
125. Suehiro A, Oura Y, Ueda M, Kakishita E. Inhibitory effect of staphylokinase on platelet aggregation. Thromb Haemost (1993) 70:834-7.
126. Liu CZ, Huang TF, Tsai PJ, Chang LY, Chang MC. A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221-550) inhibits platelet-plug formation in mice. Thromb Res (2007) 121:183-91. doi:10.1016/j.thromres.2007.03.019
127. Ferkau A, Gillmann HJ, Mischke R, Calmer S, Ecklebe S, Abid M, et al. Infection-associated platelet dysfunction of canine platelets detected in a flow chamber model. BMC Vet Res (2013) 9:112. doi:10.1186/1746-6148-9-112
128. Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie (2010) 30(10-12):14-6. doi:10.1016/j.ccm.2008.06.006
129. Cohen J. The immunopathogenesis of sepsis. Nature (2002) 420:885-91. doi:10.1038/nature01326
130. Perl M, Chung CS, Swan R, Ayala A. Role of programmed cell death in the immunopathogenesis of sepsis. Drug Discov Today Dis Mech (2007) 4:223-30. doi:10.1016/j.ddmec.2008.02.010
131. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scand J Infect Dis (2003) 35:535-44. doi:10.1080/00365540310015935
132. Tyml K. Critical role for oxidative stress, platelets, and coagulation in capillary blood flow impairment in sepsis. Microcirculation (2011) 18:152-62. doi:10.1111/j.1549-8719.2010.00080.x
133. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev (2013) 93:1247-88. doi:10.1152/physrev.00037.2012
134. Okajima K. Regulation of inflammatory responses by natural anticoagulants. Immunol Rev (2001) 184:258-74. doi:10.1034/j.1600-065x.2001.1840123.x
135. Poggi M, Paulmyer-Lacroix O, Verdier M, Peiretti F, Bastelica D, Boucraut J, et al. Chronic plasminogen activator inhibitor-1 (PAI-1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung. J Thromb Haemost (2007) 5:2467-75. doi:10.1111/j.1538-7836.2007.02757.x
136. Inwald DP, Faust SN, Lister P, Peters MJ, Levin M, Heyderman R, et al. Platelet and soluble CD40L in meningococcal sepsis. Intensive Care Med (2006) 32:1432-7. doi:10.1007/s00134-006-0250-2
137. Chew M, Rahman M, Ihrman L, Erson A, Zhang S, Thorlacius H. Soluble CD40L (CD154) is increased in patients with shock. Inflamm Res (2010) 59:979-82. doi:10.1007/s00011-010-0213-5
138. Lorente L, Martin MM, Varo N, Borreguero-Leon JM, Sole-Violan J, Blanquer J, et al. Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care (2011) 15:R97. doi:10.1186/cc10104
139. Zhang S, Rahman M, Qi Z, Thorlacius H. Simvastatin antagonizes CD40L secretion, CXC chemokine formation, and pulmonary infiltration of neutrophils in abdominal sepsis. J Leukoc Biol (2011) 89:735-42. doi:10.1189/jlb.0510279
140. Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis. J Thromb Haemost (2013) 11:1385-98. doi:10.1111/jth.12273
141. Luo L, Zhang S, Wang Y, Rahman M, Syk I, Zhang E, et al. Proinflammatory role of neutrophil extracellular traps in abdominal sepsis. Am J Physiol Lung Cell Mol Physiol (2014) 307:L586-96. doi:10.1152/ajplung.00365.2013
142. Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Ann Surg (2009) 250:783-90. doi:10.1097/SLA.0b013e3181bd95b7
143. Rahman M, Roller J, Zhang S, Syk I, Menger MD, Jeppsson B, et al. Metalloproteinases regulate CD40L shedding from platelets and pulmonary recruitment of neutrophils in abdominal sepsis. Inflamm Res (2012) 61:571-9. doi:10.1007/s00011-012-0446-6
144. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, Van Kooten C, et al. The CD40 antigen and its ligand. Annu Rev Immunol (1994) 12:881-922. doi:10.1146/annurev.iy.12.040194.004313
145. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol (2000) 67:2-17. doi:10.1189/jlb.0805480
146. Asaduzzaman M, Lavasani S, Rahman M, Zhang S, Braun OO, Jeppsson B, et al. Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med (2009) 37:1389-96. doi:10.1097/CCM.0b013e31819ceb71
147. Yost CC, Weyrich AS, Zimmerman GA. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie (2010) 92:692-7. doi:10.1016/j.biochi.2010.02.011
148. Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Spinella PC, et al. Impact of the duration of platelet storage in critically ill trauma patients. J Trauma (2011) 71:1766-73. doi:10.1097/TA.0b013e31823bdbf9
149. Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, et al. Release of potential immunomodulatory factors during platelet storage. Transfusion (2006) 46:1184-9. doi:10.1111/j.1537-2995.2006.00869.x
150. Cognasse F, Osselaer JC, Payrat JM, Chavarin P, Corash L, Garraud O. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment. Transfusion (2008) 48:809-13. doi:10.1111/j.1537-2995.2008.01655.x
151. Nguyen KA, Hamzeh-Cognasse H, Sebban M, Fromont E, Chavarin P, Absi L, et al. A computerized prediction model of hazardous inflammatory platelet transfusion outcomes. PLoS One (2014) 9:e97082. doi:10.1371/journal.pone.0097082
152. Hamzeh-Cognasse H, Damien P, Nguyen KA, Arthaud CA, Eyraud MA, Chavarin P, et al. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion (2014) 54:613-25. doi:10.1111/trf.12378
153. Wong HR, Cvijanovich NZ, Hall M, Allen GL, Thomas NJ, Freishtat RJ, et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children. Crit Care (2012) 16:R213. doi:10.1186/cc11847
154. Hamzeh-Cognasse H, Damien P, Nguyen KA, Zeni F, Pozzetto B, Cognasse F, et al. Contribution of activated platelets to plasma IL-27 levels. Crit Care (2013) 17:411. doi:10.1186/cc11925
155. Nomura S, Fujita S, Nakanishi T, Yokoi T, Shimamoto K, Miyamoto R, et al. Platelet-derived microparticles cause CD154-dependent activation of dendritic cells. Platelets (2012) 23:81-2. doi:10.3109/09537104.2011.595850
156. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest (1995) 25:843-51. doi:10.1111/j.1365-2362.1995.tb01694.x
157. Johansson D, Shannon O, Rasmussen M. Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PLoS One (2011) 6:e26928. doi:10.1371/journal.pone.0026928
158. Kahn F, Hurley S, Shannon O. Platelets promote bacterial dissemination in a mouse model of streptococcal sepsis. Microbes Infect (2013) 15:669-76. doi:10.1016/j.micinf.2013.05.003
159. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung (2010) 39:21-6. doi:10.1016/j.hrtlng.2009.07.005
160. Gafter-Gvili A, Mansur N, Bivas A, Zemer-Wassercug N, Bishara J, Leibovici L, et al. Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc (2011) 86:389-96. doi:10.4065/mcp.2010.0705
161. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, De Lassence A, Zahar JR, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest (2007) 131:1735-41. doi:10.1378/chest.06-2233
162. Dormehl IC, Kilian JG, Maree M, Jacobs L. Investigation by scintigraphic methods of platelet kinetics under normal and septic shock conditions in the experimental baboon model. Am J Physiol Imaging (1990) 5:75-9.
163. McKenzie SE, Taylor SM, Malladi P, Yuhan H, Cassel DL, Chien P, et al. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol (1999) 162:4311-8.
164. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med (1997) 103:114-20. doi:10.1016/S0002-9343(97)00136-8
165. Zakynthinos SG, Papanikolaou S, Theodoridis T, Zakynthinos EG, Christopoulou-Kokkinou V, Katsaris G, et al. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med (2004) 32:1004-10. doi:10.1097/01.CCM.0000121433.61546.A0
166. Secor D, Li F, Ellis CG, Sharpe MD, Gross PL, Wilson JX, et al. Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med (2010) 36:1928-34. doi:10.1007/s00134-010-1969-3
167. Josefsson EC, White MJ, Dowling MR, Kile BT. Platelet life span and apoptosis. Methods Mol Biol (2012) 788:59-71. doi:10.1007/978-1-61779-307-3_5
168. Leytin V. Apoptosis in the anucleate platelet. Blood Rev (2012) 26:51-63. doi:10.1016/j.blre.2011.10.002
169. Nguyen KA, Hamzeh-Cognasse H, Palle S, Anselme-Bertrand I, Arthaud CA, Chavarin P, et al. Role of siglec-7 in apoptosis in human platelets. PLoS One (2014) 9:e106239. doi:10.1371/journal.pone.0106239
170. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 35:495-516. doi:10.1080/01926230701320337
171. Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ. The mechanism of apoptosis in human platelets during storage. Transfusion (2000) 40:1320-9. doi:10.1046/j.1537-2995.2000.40111320.x
172. Leytin V, Allen DJ, Mykhaylov S, Lyubimov E, Freedman J. Thrombin-triggered platelet apoptosis. J Thromb Haemost (2006) 4:2656-63. doi:10.1111/j.1538-7836.2006.02200.x
173. Qi B, Hardwick JM. A Bcl-xL timer sets platelet life span. Cell (2007) 128:1035-6. doi:10.1016/j.cell.2007.03.002
174. Kraemer BF, Campbell RA, Schwertz H, Franks ZG, Vieira De Abreu A, Grundler K, et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood (2012) 120:5014-20. doi:10.1182/blood-2012-04-420661
175. Yamakawa K, Ogura H, Koh T, Ogawa Y, Matsumoto N, Kuwagata Y, et al. Platelet mitochondrial membrane potential correlates with severity in patients with systemic inflammatory response syndrome. J Trauma Acute Care Surg (2013) 74:411-7. doi:10.1097/TA.0b013e31827a34cf
176. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science (2004) 303:1532-5. doi:10.1126/science.1092385
177. Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost (2008) 6:415-20. doi:10.1111/j.1538-7836.2007.02865.x
178. von Kockritz-Blickwede M, Nizet V. Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med (2009) 87:775-83. doi:10.1007/s00109-009-0481-0
179. Chow OA, Von Kockritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, Cogen AL, et al. Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe (2010) 8:445-54. doi:10.1016/j.chom.2010.10.005
180. Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med (2011) 17:1381-90. doi:10.1038/nm.2514
181. Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ (2009) 16:1438-44. doi:10.1038/cdd.2009.96
182. Wong CH, Jenne CN, Petri B, Chrobok NL, Kubes P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat Immunol (2013) 14:785-92. doi:10.1038/ni.2631